Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells*
暂无分享,去创建一个
[1] D A Agard,et al. The role of pro regions in protein folding. , 1993, Current opinion in cell biology.
[2] Alexander Pertsemlidis,et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.
[3] R. Hammer,et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Breslow,et al. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] K Nakayama,et al. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. , 1997, The Biochemical journal.
[6] H. Khorana,et al. Structure and function in rhodopsin: high level expression of a synthetic bovine opsin gene and its mutants in stable mammalian cell lines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] N. Seidah,et al. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells Published, JLR Papers in Press, March 1, 2005. DOI 10.1194/jlr.M400396-JLR200 , 2005, Journal of Lipid Research.
[8] G. Thomas,et al. The Ordered and Compartment-specific Autoproteolytic Removal of the Furin Intramolecular Chaperone Is Required for Enzyme Activation* , 2002, The Journal of Biological Chemistry.
[9] Jonathan C. Cohen,et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.
[10] Jonathan C. Cohen,et al. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. , 2006, American journal of human genetics.
[11] Jay D. Horton,et al. Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver* , 2004, Journal of Biological Chemistry.
[12] Annik Prat,et al. The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR , 2007, Traffic.
[13] A. Prat,et al. NARC-1/PCSK9 and Its Natural Mutants , 2004, Journal of Biological Chemistry.
[14] Jonathan C. Cohen,et al. Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* , 2007, Journal of Biological Chemistry.
[15] J. Weissenbach,et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.
[16] T. Ranheim,et al. Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. , 2006, Human molecular genetics.
[17] A. Prat,et al. The proprotein convertases and their implication in sterol and/or lipid metabolism , 2006, Biological chemistry.
[18] E. Fisher,et al. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] N. Seidah,et al. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. , 1993, The Biochemical journal.
[20] C. Slaughter,et al. Secreted Site-1 Protease Cleaves Peptides Corresponding to Luminal Loop of Sterol Regulatory Element-binding Proteins* , 1999, The Journal of Biological Chemistry.
[21] A. Prat,et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Xiayang Qiu,et al. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia , 2007, Nature Structural &Molecular Biology.
[23] B. Ozenberger,et al. Functional characterization of Narc 1, a novel proteinase related to proteinase K. , 2003, Archives of biochemistry and biophysics.
[24] G. Thomas,et al. Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. , 1994, The EMBO journal.
[25] R. Hammer,et al. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. , 2006, The Journal of clinical investigation.
[26] N. Seidah,et al. Eukaryotic protein processing: endoproteolysis of precursor proteins. , 1997, Current opinion in biotechnology.